Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159
Clinical trial NCT05082779 · COMPLETED
Trial details
- NCT number
- NCT05082779
- Sponsor
- Cascade Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-26
- Primary completion
- 2022-09-16
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.